EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Long‐acting growth hormone in 2022

Margaret Steiner, Jacklyn Frank, Paul Saenger

Pediatric Investigation · 2023-03 · 7 (1) · 36-42

DOI: 10.1002/ped4.12358 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Investigation, online erschienen am 03.01.2023. Verfasst von Margaret Steiner und 2 weiteren Autor:innen. Beteiligte Einrichtung: NYU Langone Health-Long Island 101 Mineola Boulevard Mineola New York USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

After the isolation of pituitary growth hormone (GH) in 1957, this form of GH, always in limited supply, was the only drug available for the treatment of GH deficiency. In 1985, recombinant GH became available, and the modalities of GH therapies changed dramatically as the supply was unlimited. New indications for GH in pediatrics and adult medicine were developed. Treatment was daily. Now in 2021 long‐acting GH (LAGH) became available the world over making GH therapy more patient‐friendly and even showing slightly greater efficacy than daily GH therapy. We are now entering a new era of LAGH therapy for pediatric and adult use with new formulations of GH, which will predictably be the preferred form of GH therapy for years to come increasing adherence to GH therapy and possibly even efficacy, that is, better growth rate. The continued availability of new safety data will further solidify the use of LAGH in clinical medicine.

Schlagwörter

Stichwörter der Autor:innen

Albumin binding of growth hormoneGrowth hormone fusion proteinsLong‐acting growth hormonePegylation of growth hormoneProdrug of growth hormone

Autor:innen und Institutionen

  • NYU Langone Health-Long Island 101 Mineola Boulevard Mineola New York USA.

Zitieren

APA

Steiner, M., Frank, J., & Saenger, P. (2023). Long‐acting growth hormone in 2022. Pediatric Investigation, 7(1), 36-42. https://doi.org/10.1002/ped4.12358

Vancouver

Steiner M, Frank J, Saenger P. Long‐acting growth hormone in 2022. Pediatric Investigation. 2023;7(1):36-42. doi:10.1002/ped4.12358

BibTeX
@article{Steiner2023,
  author = {Steiner, Margaret and Frank, Jacklyn and Saenger, Paul},
  title = {Long‐acting growth hormone in 2022},
  journal = {Pediatric Investigation},
  year = {2023},
  volume = {7},
  number = {1},
  pages = {36--42},
  doi = {10.1002/ped4.12358}
}
Kostenlos starten →